InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Current Value
$2.001 Year Return
Current Value
$2.001 Year Return
Market Cap
$113.06M
P/E Ratio
-1.83
1Y Stock Return
31.51%
1Y Revenue Growth
178.84%
Dividend Yield
0.00%
Price to Book
1.6
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where InflaRx N.V. (NASDAQ:IFRX) stands against the other German stocks. In Germany, the economic growth is based on industry. According to Deutschland.de, Germany’s manufacturing industry contributed 26.6% to the country’s gross […]
Yahoo
JENA, Germany, Nov. 15, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization of GOHIBIC (vilobelimab), under exceptional circumstances for the treatment of adult patients with SARS-CoV-2-induced acute respirato
Finnhub
InflaRx Receives Positive CHMP Opinion for GOHIBIC® for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome ...
Yahoo
As the post-election stock market rally loses steam, major indexes in the United States have shown mixed results, reflecting investor uncertainty amid fluctuating interest rates and inflation data. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to capture attention for their potential value and growth opportunities. Though the term "penny stocks" may seem outdated, these investments can still offer unique prospects when backed by strong financials...
Yahoo
Inflarx N.V. ( (IFRX) ) has released its Q3 earnings. Here is a breakdown of the information Inflarx N.V. presented to its investors. InflaRx N.V. is a biopharmaceutical company focused on developing anti-inflammatory therapeutics, particularly targeting the complement system, with its lead product candidate being vilobelimab. The company recently released its third-quarter 2024 financial results, showcasing significant milestones in their clinical trials and ongoing financial stability. Key hig
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INGN | -<0.01% | $226.04M | +63.06% | 0.00% |
NR | -<0.01% | $620.19M | +0.14% | 0.00% |
NPO | -0.01% | $3.64B | +36.09% | 0.69% |
ECL | -0.02% | $69.18B | +30.92% | 0.93% |
ANGI | -0.03% | $987.36M | -5.71% | 0.00% |
RUSHA | -0.05% | $4.66B | +53.97% | 1.18% |
CEG | -0.05% | $73.37B | +91.48% | 0.59% |
VAL | 0.06% | $3.30B | -30.96% | 0.00% |
CNM | -0.06% | $8.65B | +31.42% | 0.00% |
BMI | 0.06% | $6.21B | +43.25% | 0.55% |
MITK | -0.06% | $401.51M | -22.13% | 0.00% |
CNQ | -0.07% | $71.04B | +1.89% | 6.81% |
LITE | -0.08% | $5.67B | +92.08% | 0.00% |
ST | 0.09% | $4.63B | -2.58% | 1.56% |
JBT | -0.09% | $3.76B | +11.25% | 0.34% |
DT | 0.09% | $15.40B | -1.30% | 0.00% |
JAMF | -0.10% | $1.89B | -10.98% | 0.00% |
LII | -0.10% | $22.21B | +51.90% | 0.72% |
NBR | -0.11% | $694.91M | -21.77% | 0.00% |
IMUX | -0.11% | $94.58M | -1.41% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OMER | 31.97% | $349.44M | +258.93% | 0.00% |
CHMI | 26.75% | $84.12M | -31.97% | 22.58% |
CCRN | 26.49% | $341.35M | -50.81% | 0.00% |
ERIC | 26.42% | $25.52B | +67.88% | 3.20% |
ALDX | 26.17% | $294.18M | +102.46% | 0.00% |
EBC | 25.87% | $3.95B | +50.04% | 2.40% |
OGS | 25.71% | $4.33B | +29.46% | 3.46% |
DNLI | 25.42% | $3.50B | +33.66% | 0.00% |
NVCR | 25.42% | $1.78B | +34.75% | 0.00% |
WSBF | 25.14% | $295.44M | +27.51% | 3.93% |
AMAL | 25.06% | $1.08B | +69.89% | 1.30% |
GTY | 24.94% | $1.81B | +13.14% | 5.51% |
BHVN | 24.91% | $4.67B | +56.79% | 0.00% |
NPWR | 24.76% | $972.21M | +24.83% | 0.00% |
ARR | 24.47% | $1.05B | +8.10% | 16.27% |
OGN | 24.43% | $3.76B | +32.28% | 7.69% |
FRST | 24.42% | $302.36M | +21.93% | 3.29% |
LNT | 24.30% | $15.97B | +26.81% | 3.08% |
SMPL | 24.29% | $3.81B | -3.16% | 0.00% |
BKH | 24.21% | $4.49B | +23.18% | 4.16% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
STNE | -20.89% | $2.84B | -32.36% | 0.00% |
AVGO | -15.88% | $772.28B | +68.52% | 9.87% |
NVDA | -15.42% | $3.61T | +194.35% | 0.07% |
VRT | -15.30% | $52.90B | +230.61% | 0.07% |
VSTA | -14.87% | $204.94M | -39.33% | 0.00% |
CLS | -14.05% | $10.10B | +223.71% | 0.00% |
KLAC | -13.48% | $82.35B | +11.80% | 0.98% |
MPWR | -13.07% | $28.58B | +8.88% | 0.82% |
GE | -12.77% | $192.17B | +85.70% | 0.52% |
PGR | -12.53% | $149.10B | +57.29% | 0.45% |
AMD | -12.53% | $226.20B | +16.98% | 0.00% |
TDG | -12.51% | $70.32B | +35.98% | 0.00% |
KBR | -12.46% | $7.77B | +11.73% | 1.00% |
MU | -12.31% | $108.36B | +27.40% | 0.47% |
GDDY | -12.29% | $26.31B | +101.81% | 0.00% |
PSN | -12.28% | $10.03B | +50.06% | 0.00% |
LRCX | -12.21% | $90.29B | -0.80% | 11.86% |
OCX | -12.19% | $42.93M | -36.09% | 0.00% |
EDN | -11.98% | $813.00M | +161.34% | 0.00% |
SNPS | -11.97% | $82.03B | -1.18% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 27.31% | $6.58B | 0.35% |
SMMV | 25.77% | $321.07M | 0.2% |
SMDV | 25.74% | $754.57M | 0.4% |
IJS | 25.42% | $7.37B | 0.18% |
XMLV | 25.29% | $976.94M | 0.25% |
ARKK | 25.16% | $6.28B | 0.75% |
XHE | 24.97% | $213.41M | 0.35% |
FYX | 24.91% | $959.00M | 0.6% |
SLYV | 24.86% | $4.16B | 0.15% |
VIOV | 24.70% | $1.44B | 0.15% |
GNOM | 24.56% | $70.59M | 0.5% |
EDOC | 24.46% | $40.86M | 0.68% |
DES | 24.44% | $2.13B | 0.38% |
XSHD | 24.43% | $54.49M | 0.3% |
BBRE | 24.13% | $970.81M | 0.11% |
IWN | 23.75% | $13.17B | 0.24% |
IBB | 22.74% | $6.66B | 0.45% |
XPH | 22.66% | $157.87M | 0.35% |
VPC | 21.95% | $52.32M | 9.72% |
RSPA | 21.65% | $273.87M | 0% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FTQI | 0.02% | $492.22M | 0.75% |
USSG | 0.18% | $959.04M | 0.09% |
BOTZ | -0.21% | $2.57B | 0.68% |
FLQL | -0.23% | $1.46B | 0.29% |
FDMO | -0.27% | $365.25M | 0.15% |
TDIV | -0.40% | $2.82B | 0.5% |
KWEB | 0.42% | $5.94B | 0.7% |
DYNF | -0.43% | $12.90B | 0.3% |
OEF | -0.46% | $14.41B | 0.2% |
ONEQ | -0.50% | $7.14B | 0.21% |
IBTE | 0.52% | $1.70B | 0.07% |
CSHI | -0.52% | $482.85M | 0.38% |
NANC | 0.61% | $194.02M | 0.76% |
EMQQ | 0.61% | $374.21M | 0.86% |
FTLS | -0.64% | $1.62B | 1.46% |
HEZU | 0.64% | $334.98M | 0.53% |
PLDR | -0.66% | $676.26M | 0.59% |
VRP | -0.74% | $1.83B | 0.5% |
SIXG | 0.74% | $569.71M | 0.3% |
FTGC | 0.75% | $2.17B | 1.02% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EQLS | -15.44% | $76.08M | 1% |
SGOV | -13.71% | $27.53B | 0.09% |
BTAL | -12.75% | $388.04M | 1.43% |
SMH | -11.75% | $23.66B | 0.35% |
MTUM | -11.18% | $13.13B | 0.15% |
CORN | -10.99% | $61.12M | 0.2% |
VCAR | -10.87% | $9.00M | 1.2% |
KLIP | -10.84% | $125.85M | 0.93% |
SOXX | -10.79% | $13.20B | 0.35% |
SOXQ | -10.75% | $490.35M | 0.19% |
IGPT | -10.56% | $407.54M | 0.58% |
PSI | -9.75% | $711.93M | 0.56% |
IBMM | -9.62% | $391.28M | 0.18% |
VIXY | -9.30% | $195.31M | 0.85% |
FTXL | -9.07% | $1.31B | 0.6% |
HIGH | -8.98% | $302.78M | 0.51% |
DBE | -8.94% | $50.13M | 0.77% |
DBO | -8.84% | $217.57M | 0.77% |
XBIL | -8.79% | $637.70M | 0.15% |
WEAT | -8.75% | $120.27M | 0.28% |